Realheart targets February 2028 readiness for first-in-human implant of total artificial heart

• Scandinavian Real Heart set a strategic target to be ready for first-in-human implantation of its Realheart Total Artificial Heart in February 2028.
• Planning centers on scaling production capacity through new facilities, headcount growth, process upgrades, an ERP rollout for finance and production planning.
• Development work targets a 10-day in vivo implantation study, supported by ethics approval for chronic studies at Sahlgrenska University Hospital.
• Six-month full-system reliability evidence is now expected in Q1 2027, pushing a key readiness milestone later than previously planned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scandinavian Real Heart AB published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.